Skip to main content

Table 1 Patient characteristics

From: Determination of caspase-3 activation fails to predict chemosensitivity in primary acute myeloid leukemia blasts

Patients diagnosed with AML, no

42

Age [years]: median (range)

45 (19 – 73)

Female/male ratio, no

16/26

Successful DiSC-assays, no (%)

37/42 (88%)

Successful Casp3-tests, no (%)

42/42 (100%)

   Successful single drug tests, no (%)

116/126 (92%)

DiSC-assay / Casp3-test correlation, no (%)

37/42 (88%)

   Correlation between single drugs, no (%)

94/126 (75%)

FAB-groups

No

M1

3

M2

12

M3

4

M4

10

M5

5

M6

1

Secondary AML

7